U
SGYP

UBS’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

UBS’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$266K Buy
95,500
+5,600
+6% +$20.3K ﹤0.01% 4895
2014
Q2 		$366K Sell
89,900
-44,950
-33% -$191K ﹤0.01% 4538
2014
Q1 		$716K Buy
134,850
+90,842
+206% +$509K ﹤0.01% 3853
2013
Q4 		$244K Buy
44,008
+12,067
+38% +$52K ﹤0.01% 5091
2013
Q3 		$144K Buy
+31,941
New +$143K ﹤0.01% 5586

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

UBS's SGYP Position: Q3 2014 in Review

UBS increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 6.2% in Q3 2014, buying an estimated $20.3K and bringing the position to 95,500 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #4895.

UBS first reported a position in SGYP in Q3 2013 and has held it in 5 quarters since. The position peaked at $716K in Q1 2014. 78 funds tracked by Wall St. Rank hold SGYP as of Q3 2014.

  • UBS held 95,500 shares of Synergy Pharmaceuticals, Inc Common Stock worth $266K as of Q3 2014.
  • UBS bought 5,600 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2014, an estimated $20.3K.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4895 holding.
  • UBS first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and has held it in 5 quarters since.
  • UBS's Synergy Pharmaceuticals, Inc Common Stock position peaked at $716K in Q1 2014.
  • 78 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.